BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17362235)

  • 1. Fumaric acid esters in the management of severe psoriasis.
    Brewer L; Rogers S
    Clin Exp Dermatol; 2007 May; 32(3):246-9. PubMed ID: 17362235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria with fumaric acid ester treatment for psoriasis.
    Ogilvie S; Lewis Jones S; Dawe R; Foerster J
    Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug survival of fumaric acid esters for psoriasis: a retrospective study.
    Ismail N; Collins P; Rogers S; Kirby B; Lally A
    Br J Dermatol; 2014 Aug; 171(2):397-402. PubMed ID: 24471408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experience.
    Heelan K; Markham T
    Clin Exp Dermatol; 2012 Oct; 37(7):793-5. PubMed ID: 22548419
    [No Abstract]   [Full Text] [Related]  

  • 6. Nail psoriasis improvement in a patient treated with fumaric acid esters.
    Vlachou C; Berth-Jones J
    J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
    Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
    Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomodulation with fumaric acid. Systemic therapy in psoriasis].
    Sebók B; Schneider I
    Orv Hetil; 2000 Jan; 141(3):129-32. PubMed ID: 10693335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study.
    Dickel H; Bruckner T; Altmeyer P
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
    Kaur I; Dogra S; De D; Kanwar AJ
    Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients.
    Kokelj F; Plozzer C; Avian A; Trevisan G
    Acta Dermatovenerol Croat; 2009; 17(3):170-5. PubMed ID: 19818215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumaric acid esters.
    Rostami Yazdi M; Mrowietz U
    Clin Dermatol; 2008; 26(5):522-6. PubMed ID: 18755371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumaric acid esters for severe psoriasis: the Leicestershire experience.
    Sladden MJ; Osborne JE; Hutchinson PE
    Br J Dermatol; 2006 Oct; 155(4):843-4. PubMed ID: 16965442
    [No Abstract]   [Full Text] [Related]  

  • 14. Fumaric acid esters (FAEs) suppress CD 15- and ODP 4-positive cells in psoriasis.
    Bacharach-Buhles M; Pawlak FM; Matthes U; Joshi RK; Altmeyer P
    Acta Derm Venereol Suppl (Stockh); 1994; 186():79-82. PubMed ID: 7915483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumaric acid esters for psoriasis: a systematic review.
    Smith D
    Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fumaric acid esters in psoriasis.
    Fika Z; Williams RE; Williamson DJ
    Br J Dermatol; 2006 Mar; 154(3):567-8. PubMed ID: 16445802
    [No Abstract]   [Full Text] [Related]  

  • 17. Fumaric acid ester-induced T-cell lymphopenia in the real-life treatment of psoriasis.
    Dickel H; Bruckner T; Höxtermann S; Dickel B; Trinder E; Altmeyer P
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):893-905. PubMed ID: 30680823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris].
    Mrowietz U; Rostami-Yazdi M; Neureither M; Reich K
    J Dtsch Dermatol Ges; 2009 Apr; 7 Suppl 2():S3-16. PubMed ID: 19522921
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term treatment with fumaric acid esters in an 11-year-old male child with psoriasis.
    Gerdes S; Domm S; Mrowietz U
    Dermatology; 2011; 222(3):198-200. PubMed ID: 21502753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fumaric acid esters, their place in the treatment of psoriasis.
    Ormerod AD; Mrowietz U
    Br J Dermatol; 2004 Apr; 150(4):630-2. PubMed ID: 15099356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.